Health Care: Drugs

OncoMed Pharmaceuticals Inc (OMED: NASDAQ)

$25.96 n/a | n/a%
03/03/15 - 03:59 PM ET
Company Profile
Price and Volume
Recent Price 25.96
52 Week High 39.50
52 Week Low 16.57
Avg. Daily Vol. (Mil) 0.17
Beta (3 year) 0.00
Share Related Items
Mkt Cap (Mil) 774.44
Shares Out (Mil) 29.83
Float (Mil) 13.21
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.20
Current Ratio 6.30
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 15.48
Price/Book 8.66
Price/Cash Flow -20.40
Per Share Data
Earnings -0.56
Sales 1.68
Book Value 3.00
Cash Flow -1.27
Business Summary
OncoMed Pharmaceuticals Inc is a clinical development-stage biotechnology company focused on discovering and developing first-in-class monoclonal antibody therapeutics targeting cancer stem cells.
General Information
800 Chesapeake Drive
Redwood City, CA 94063
Industry : Drugs
Sector: Health Care
Employees: 91
CEO: Paul J. Hastings
Short Interest
Current Month (Mil) 2.12
Previous Month (Mil) 2.36
Short Interest Ratio (Days) 12.60
Management Effectiveness
Return on Equity n.a.
Return on Assets -14.60
Return on Investments -43.90
Gross Margin n.a.
EBIT Margin -77.80
Profit Margin -78.60

Portfolios with OMED

Latest OMED Headlines from TheStreet

More Financial News for OMED

Press Releases for OMED

See All Press Releases

Partner Headlines for OMED

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter